---
document_datetime: 2023-09-21 20:39:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/xeljanz-epar-all-authorised-presentations_en.pdf
document_name: xeljanz-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.8742707
conversion_datetime: 2025-12-23 00:35:58.945511
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging   | Content (Concentration)   | Pack size                |
|------------------|-------------------|------------|--------------------------|---------------------------|-----------------------|---------------------------|--------------------------|
| EU/1/17/1178/001 | Xeljanz           | 5 mg       | Film-coated tablet       | Oral use                  | bottle (HDPE)         | N/A                       | 60 tablets               |
| EU/1/17/1178/002 | Xeljanz           | 5 mg       | Film-coated tablet       | Oral use                  | bottle (HDPE)         | N/A                       | 180 tablets              |
| EU/1/17/1178/003 | Xeljanz           | 5 mg       | Film-coated tablet       | Oral use                  | blister (alu/PVC/alu) | N/A                       | 56 tablets               |
| EU/1/17/1178/004 | Xeljanz           | 5 mg       | Film-coated tablet       | Oral use                  | blister (alu/PVC/alu) | N/A                       | 182 tablets              |
| EU/1/17/1178/005 | Xeljanz           | 10 mg      | Film-coated tablet       | Oral use                  | bottle (HDPE)         | N/A                       | 60 tablets               |
| EU/1/17/1178/006 | Xeljanz           | 10 mg      | Film-coated tablet       | Oral use                  | bottle (HDPE)         | N/A                       | 180 tablets              |
| EU/1/17/1178/007 | Xeljanz           | 10 mg      | Film-coated tablet       | Oral use                  | blister (alu/PVC/alu) | N/A                       | 56 tablets               |
| EU/1/17/1178/008 | Xeljanz           | 10 mg      | Film-coated tablet       | Oral use                  | blister (alu/PVC/alu) | N/A                       | 112 tablets              |
| EU/1/17/1178/009 | Xeljanz           | 10 mg      | Film-coated tablet       | Oral use                  | blister (alu/PVC/alu) | N/A                       | 182 tablets              |
| EU/1/17/1178/010 | Xeljanz           | 11 mg      | Prolonged release tablet | Oral use                  | bottle (HDPE)         | N/A                       | 30 tablets               |
| EU/1/17/1178/011 | Xeljanz           | 11 mg      | Prolonged release tablet | Oral use                  | bottle (HDPE))        | N/A                       | 90 tablets               |
| EU/1/17/1178/012 | Xeljanz           | 11 mg      | Prolonged release tablet | Oral use                  | blister (alu/PVC/alu) | N/A                       | 28 tablets               |
| EU/1/17/1178/013 | Xeljanz           | 11 mg      | Prolonged release tablet | Oral use                  | blister (alu/PVC/alu) | N/A                       | 91 tablets               |
| EU/1/17/1178/014 | Xeljanz           | 5 mg       | Film-coated tablet       | Oral use                  | blister (alu/PVC/alu) | N/A                       | 112 tablets              |
| EU/1/17/1178/015 | Xeljanz           | 1 mg/ml    | Oral solution            | Oral use                  | Bottle (HDPE)         | 250 ml                    | 1 bottle + 1 syringe + 1 |